Sign up to save your podcasts
Or
Share PARP Inhibitors for Ovarian Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
PARP Inhibitors for Ovarian Cancer
We interview two prominent ovarian cancer researchers from both sides of the Atlantic, Dr. Michael Birrer and Dr. Jonathan Ledermann, on the role of PARP inhibitors and the challenges of developing ovarian cancer therapies.
View all episodes
By Cancer NetworkWe interview two prominent ovarian cancer researchers from both sides of the Atlantic, Dr. Michael Birrer and Dr. Jonathan Ledermann, on the role of PARP inhibitors and the challenges of developing ovarian cancer therapies.